Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells

Epratuzumab has demonstrated therapeutic activity in patients with non-Hodgkin lymphoma, acute lymphoblastic leukemia, systemic lupus erythematosus, and Sjögren's syndrome, but its mechanism of affecting normal and malignant B cells remains incompletely understood. We reported previously that e...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:MAbs
Main Authors: Chang, Chien-Hsing, Wang, Yang, Gupta, Pankaj, Goldenberg, David M
Format: Artigo
Sprog:Inglês
Udgivet: Taylor & Francis 2014
Fag:
Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622945/
https://ncbi.nlm.nih.gov/pubmed/25484043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/19420862.2014.979081
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker